Feasibility and safety of robotic-assisted pancreatectomy for pancreatic tumor

Feasibility and safety of robotic-assisted pancreatectomy with Da Vinci Si surgical system for pancreatic tumor - RADP01 study for pancreatic tumor

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs022180048

Enrollment

Registered

2019-03-26

Start date

2018-03-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic neoplasms pancreatic tumor

Interventions

robotic surgery

robotic surgery, pancreatic tumor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age: From 20y.o. to 85y.o. Disease 1. pancreatic benign tumor 2. pancreatic neuroendocrine tumor 3. IPMN 4. pancreatic cystic tumor 5. pancreatic duct adenocaricnoma (classified as Resectable)

Exclusion criteria

Exclusion criteria: 1. Unresectable pancreatic cancer 2. Borderline resectable pancreatic cancer 3. Poor performance status 4. Case which is not appropriate for this clinical study 5. Case in which informed consent is not obtained

Design outcomes

Primary

Measure	Time frame
Morbidity rate exceeding Grade 3 in Clavien-Dindoclaasification	—

Secondary

Measure	Time frame
1. hospital stay 2. conversion rate 3. number of dissected lymph nodes 4. R0 resection rate 5. postoperative quality of life (SF-36)	—

Contacts

Public ContactKeinosuke Ishido

Department of Gastroenterological Surgery, Hirosaki UNiversity Graduate School of Medicine

k-ishido@hirosaki-u.ac.jp+81-172395079

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026